Chronic inflammatory demyelinating polyneuropathy

Journal of the Neurological Sciences

Volumn 333, Issue 1-2, 2013, Pages 37-42

  Mathey, Emily K ^a   Pollard, John D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antibody; Autoimmune; CIDP; Conduction block; Corticosteroids; Intravenous immunoglobulin; Node of Ranvier; Paranode; Polyradiculoneuropathy; Schwann cell

Indexed keywords

ALEMTUZUMAB; ANTIBODY; ANTIGEN; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; GADOLINIUM; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; ION CHANNEL; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEPREDNISONE; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELIN; PREDNISONE; RITUXIMAB; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; AUTOPSY; B LYMPHOCYTE; BRAIN ELECTROPHYSIOLOGY; CD8+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; CRANIAL NERVE; DEMYELINATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ELECTRODIAGNOSIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LOW DRUG DOSE; META ANALYSIS; MOTOR NERVE CONDUCTION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RISK FACTOR; T LYMPHOCYTE; TREATMENT DURATION;

ANTIBODY; AUTOIMMUNE; CIDP; CONDUCTION BLOCK; CORTICOSTEROIDS; INTRAVENOUS IMMUNOGLOBULIN; NODE OF RANVIER; PARANODE; POLYRADICULONEUROPATHY; SCHWANN CELL;

ADRENAL CORTEX HORMONES; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; PLASMA EXCHANGE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 84884349372     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.10.020     Document Type: Article

References (68)

1. P.Y. Van den Bergh, R.D. Hadden, P. Bouche, D.R. Cornblath, A. Hahn, and I. Illa European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision Eur J Neurol 17 3 Mar 2010 356 363
2. N. Latov Diagnosis of CIDP Neurology 59 12 Suppl. 6 Dec 24, 2002 S2 S6
3. H.H. Hyland, and W.R. Russell Chronic progressive polyneuritis, with report of a fatal case Brain 53 3 1930 278 289
4. P.J. Dyck, A.C. Lais, M. Ohta, J.A. Bastron, H. Okazaki, and R.V. Groover Chronic inflammatory polyradiculoneuropathy Mayo Clin Proc 50 11 Nov 1975 621 637
5. A.J. Duggins, J.G. McLeod, J.D. Pollard, L. Davies, F. Yang, and E.O. Thompson Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy Brain 122 Pt 7 Jul 1999 1383 1390
6. G.K. Harvey, J.D. Pollard, K. Schindhelm, and J. Antony Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit J Neurol Sci 81 2-3 Nov 1987 215 225
7. J.W. Prineas, and J.G. McLeod Chronic relapsing polyneuritis J Neurol Sci 27 4 Apr 1976 427 458
8. J.D. Pollard, P.A. McCombe, J. Baverstock, P.A. Gatenby, and J.G. McLeod Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy J Neuroimmunol 13 2 Dec 1986 123 134
9. J.M. Spies, K.W. Westland, J.G. Bonner, and J.D. Pollard Intraneural activated T cells cause focal breakdown of the blood-nerve barrier Brain 118 Pt 4 Aug 1995 857 868
10. J.M. Spies, J.D. Pollard, J.G. Bonner, K.W. Westland, and J.G. McLeod Synergy between antibody and P2-reactive T cells in experimental allergic neuritis J Neuroimmunol 57 1-2 Mar 1995 77 84
11. B. Schmidt, K.V. Toyka, R. Kiefer, J. Full, H.P. Hartung, and J. Pollard Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy Muscle Nerve 19 4 Apr 1996 474 487
12. J.W. Prineas Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study Acta Neuropathol 18 1 1971 34 57
13. C. Sommer, S. Koch, M. Lammens, A. Gabreels-Festen, G. Stoll, and K.V. Toyka Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP Neurology 65 12 Dec 27, 2005 1924 1929
14. U. Steinhoff, and S.H. Kaufmann Specific lysis by CD8 + T cells of Schwann cells expressing Mycobacterium leprae antigens Eur J Immunol 18 6 Jun 1988 969 972
15. J.D. Pollard Chronic idiopathic demyelinating polyneuropathy and Schwann cells P.J. Armati, The biology of Schwann cells 2007 Cambridge University Press New York 171 184
16. A.F. Hahn, C.F. Bolton, N. Pillay, C. Chalk, T. Benstead, and V. Bril Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study Brain 119 Pt 4 Aug 1996 1055 1066
17. M.C. Dalakas, and W.K. Engel Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy Arch Neurol 37 10 Oct 1980 637 640
18. K. Heininger, U.G. Liebert, K.V. Toyka, F.T. Haneveld, G. Schwendemann, and V. Kolb-Bachofen Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G J Neurol Sci 66 1 Oct 1984 1 14
19. A. Khalili-Shirazi, P. Atkinson, N. Gregson, and R.A. Hughes Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy J Neuroimmunol 46 1-2 Jul 1993 245 251
20. C. Melendez-Vasquez, J. Redford, P.P. Choudhary, I.A. Gray, P. Maitland, and N.A. Gregson Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy J Neuroimmunol 73 1-2 Mar 1997 124 134
21. C.M. Gabriel, N.A. Gregson, and R.A. Hughes Anti-PMP22 antibodies in patients with inflammatory neuropathy J Neuroimmunol 104 2 May 1, 2000 139 146
22. M.F. Ritz, J. Lechner-Scott, R.J. Scott, P. Fuhr, N. Malik, and B. Erne Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies J Neuroimmunol 104 2 May 1, 2000 155 163
23. W.X. Yan, J.J. Archelos, H.P. Hartung, and J.D. Pollard P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy Ann Neurol 50 3 Sep 2001 286 292
24. M.S. Kwa, I.N. van Schaik, R.R. de Jonge, A. Brand, L. Kalaydjieva, and van BN Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies Brain 126 Pt 2 Feb 2003 361 375
25. D. Allen, K. Giannopoulos, I. Gray, N. Gregson, A. Makowska, and J. Pritchard Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy J Peripher Nerv Syst 10 2 Jun 2005 174 180
26. M.A. Su, D. Davini, P. Cheng, K. Giang, U. Fan, and J.J. DeVoss Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy J Immunol 188 10 May 15, 2012 4906 4912
27. N. Nagavalli, J. Malik, M. Anderson, and M.A. Su A new Aire-deficient model of spontaneous autoimmune peripheral neuropathy J Peripher Nerv Syst 17 2012 261 262
28. A.A. Ilyas, F.A. Mithen, M.C. Dalakas, Z.W. Chen, and S.D. Cook Antibodies to acidic glycolipids in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy J Neurol Sci 107 1 Jan 1992 111 121
29. N. Yuki, Y. Tagawa, and S. Handa Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy J Neuroimmunol 70 1 Oct 1996 1 6
30. T. Tsuruta, N. Goda, Y. Umetsu, N. Iwaya, Y. Kuwahara, and H. Hiroaki (1)H, (1)(3)C, and (1)(5)N resonance assignment of the SPFH domain of human stomatin Biomol NMR Assign 6 1 Apr 2012 23 25
31. M. Kuwahara, S. Suzuki, K. Takada, and S. Kusunoki Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy J Neuroimmunol 239 1-2 Oct 28, 2011 87 90
32. S. Rinaldi, K.M. Brennan, and H.J. Willison Combinatorial glycoarray Methods Mol Biol 808 2012 413 423
33. S. Rinaldi, K.M. Brennan, and H.J. Willison Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding Prog Lipid Res 49 1 Jan 2010 87 95
34. K. Saida, T. Saida, M.J. Brown, and D.H. Silberberg In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study Am J Pathol 95 1 Apr 1979 99 116
35. T. Saida, K. Saida, S.H. Dorfman, D.H. Silberberg, A.J. Sumner, and M.C. Manning Experimental allergic neuritis induced by sensitization with galactocerebroside Science 204 4397 Jun 8, 1979 1103 1106
36. H.J. Willison Periperal nerve antigens P.J. Dyck, P.K. Thomas, Peripheral neuropathy 4th ed. 2005 Elsevier Saunders Philadelphia 573 608
37. K. Susuki, M.N. Rasband, K. Tohyama, K. Koibuchi, S. Okamoto, and K. Funakoshi Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers J Neurosci 27 15 Apr 11, 2007 3956 3967
38. David M, Spies JM, Pollard JD, Armati PJ, Zhang G. Anti-ganglioside antibodies induce axonal conduction failure. Submitted for publication.
39. E.K. Mathey, T. Derfuss, M.K. Storch, K.R. Williams, K. Hales, and D.R. Woolley Neurofascin as a novel target for autoantibody-mediated axonal injury J Exp Med 204 10 Oct 1, 2007 2363 2372
40. C. Cifuentes-Diaz, O. Dubourg, T. Irinopoulou, M. Vigny, S. Lachkar, and L. Decker Nodes of Ranvier and paranodes in chronic acquired neuropathies PLoS One 6 1 2011 e14533
41. J.J. Devaux, M. Odaka, and N. Yuki Nodal proteins are target antigens in Guillain-Barre syndrome J Peripher Nerv Syst 17 1 Mar 2012 62 71
42. T. Derfuss, K. Parikh, S. Velhin, M. Braun, E. Mathey, and M. Krumbholz Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals Proc Natl Acad Sci U S A 106 20 May 19, 2009 8302 8307
43. E. Lancaster, M.G. Huijbers, V. Bar, A. Boronat, A. Wong, and E. Martinez-Hernandez Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia Ann Neurol 69 2 Feb 2011 303 311
44. W.X. Yan, E. Mathey, C. Yiannikas, and J.D. Pollard Antineurofascin antibodies are present in patients with peripheral demyelinating neuropathies and mediate changes in nerve conductin in animals J Peripher Nerv Syst 15 2010 288 289
45. J.D. Pollard, and P.J. Armati CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology J Peripher Nerv Syst 16 1 Mar 2011 15 23
46. A.S. Dhaunchak, C. Becker, H. Schulman, F.O. De Jr., S. Rajasekharan, and B. Banwell Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis Ann Neurol 71 5 May 2012 601 613
47. A. Lonigro, and J.J. Devaux Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis Brain 132 Pt 1 Jan 2009 260 273
48. R.A. Hughes, P. Donofrio, V. Bril, M.C. Dalakas, C. Deng, and K. Hanna Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial Lancet Neurol 7 2 Feb 2008 136 144
49. M.M. Mehndiratta, and R.A. Hughes Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy Cochrane Database Syst Rev 1 2002 CD002062
50. R.A. Hughes Chronic inflammatory demyelinating polyradiculoneuropathy Ann Neurol 50 3 Sep 2001 281 282
51. J.T. Kissel The treatment of chronic inflammatory demyelinating polyradiculoneuropathy Semin Neurol 23 2 Jun 2003 169 180
52. D.S. Molenaar, P.A. van Doorn, and M. Vermeulen Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study J Neurol Neurosurg Psychiatry 62 4 Apr 1997 388 390
53. C.L. Koski Therapy of CIDP and related immune-mediated neuropathies Neurology 59 12 Suppl. 6 Dec 24, 2002 S22 S27
54. S.A. Muley, P. Kelkar, and G.J. Parry Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids Arch Neurol 65 11 Nov 2008 1460 1464
55. P.J. Dyck, J. Daube, P. O'Brien, A. Pineda, P.A. Low, and A.J. Windebank Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy N Engl J Med 314 8 Feb 20, 1986 461 465
56. M.M. Mehndiratta, R.A. Hughes, and P. Agarwal Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy Cochrane Database Syst Rev 3 2004 CD003906
57. G.M. Yuill, W.R. Swinburn, and L.A. Liversedge Treatment of polyneuropathy with azathioprine Lancet 2 7678 Oct 24, 1970 854 856
58. P.J. Dyck, P. O'Brien, C. Swanson, P. Low, and J. Daube Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy Neurology 35 8 Aug 1985 1173 1176
59. K.C. Gorson, A.A. Amato, and A.H. Ropper Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy Neurology 63 4 Aug 24, 2004 715 717
60. A.J. Radziwill, K. Schweikert, T. Kuntzer, P. Fuhr, and A.J. Steck Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: an open-label study Eur Neurol 56 1 2006 37 38
61. D.E. Gladstone, A.A. Prestrud, and T.H. Brannagan III High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy J Peripher Nerv Syst 10 1 Mar 2005 11 16
62. M.H. Barnett, J.D. Pollard, L. Davies, and J.G. McLeod Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy Muscle Nerve 21 4 Apr 1998 454 460
63. L. Benedetti, C. Briani, D. Franciotta, R. Fazio, I. Paolasso, and C. Comi Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature J Neurol Neurosurg Psychiatry 82 3 Mar 2011 306 308
64. H.P. Hartung, H.C. Lehmann, B.C. Kieseier, and R.A. Hughes Novel treatment for immune neuropathies on the horizon J Peripher Nerv Syst 16 2 Jun 2011 75 83
65. E.A. Marsh, C.L. Hirst, J.G. Llewelyn, M.D. Cossburn, M.M. Reilly, and A. Krishnan Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy J Neurol 257 6 Jun 2010 913 919
66. M. Donaghy, K.R. Mills, S.J. Boniface, J. Simmons, I. Wright, and N. Gregson Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin J Neurol Neurosurg Psychiatry 57 7 Jul 1994 778 783
67. K.C. Gorson, I.N. van Schaik, I.S. Merkies, R.A. Lewis, R.J. Barohn, and C.L. Koski Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice J Peripher Nerv Syst 15 4 Dec 2010 326 333
68. M.C. Dalakas Advances in the diagnosis, pathogenesis and treatment of CIDP Nat Rev Neurol 7 9 Sep 2011 507 517